Company intelligence / Profile preview

Abyssinia Biologics

Durham or Portsmouth*, New Hampshire, United Statesaby-bio.com ↗

Ownership: Private
Employees: ~10
Development stage: Preclinical

Overview

Abyssinia Biologics has developed proprietary monoclonal antibodies that selectively bind toxic soluble amyloid-beta oligomers implicated in early Alzheimer’s pathology. Their lead candidates have demonstrated high selectivity in preclinical studies compared to other anti-Aβ therapies. The company also published data on an ultra-sensitive plasma immunoassay capable of detecting these toxic species as a potential companion diagnostic. All programs remain at the preclinical stage with no reported clinical trial results yet.

Therapeutic areas: Neurology
Modalities: Monoclonal antibodies (mAbs)Immunoassays/DiagnosticsVaccines (preclinical immunogen)
Industry: Biotech

Drug pipeline

5 assets

ABY-71A1

Preclinical

4 more assets in the full pipeline.

Request access →

Partnerships

Actively seeking partnerships in CNS space but none publicly announced yet.

Beyond the preview

Go deeper on Abyssinia Biologics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Abyssinia Biologics.

Explore the full profile